Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Strategy Inc. (MSTR) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Strategy Inc.Trade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Strategy Inc. vs Roivant Sciences Ltd. Common Shares — how do they compare? Strategy Inc. trades at $153.99 (market cap $60.40B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Strategy Inc. is far larger — about 2.4× Roivant Sciences Ltd. Common Shares's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Strategy Inc. for 112 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

MSTRROIV
Market Cap
$60.40B$24.72B
Volume
23,421,8306,279,442
Sector
TechnologyHealth
52-Week High
$320.29$41.81
52-Week Low
$82.31$16.04
Typical Hold Time
112 Days0 Days
Enterprise Value
$79.16B$20.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Strategy Inc.

MSTR stock trades at $153.37, down 6.79% today, reflecting volatility despite a bullish technical signal. The company reported a net loss of $3.85B in 2025 with a negative net income margin of -6,102.96%, though revenue grew slightly to $477.23M. Analyst consensus remains optimistic with a $252 price target, but earnings misses in recent quarters highlight operational challenges.

The outlook hinges on improving profitability and Bitcoin market stability, offering upside if earnings rebound. Key risks include persistent losses, high debt, and sensitivity to macroeconomic factors. Investors should weigh analyst optimism against fundamental weaknesses before considering a position.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTR
54% Buy46% Sell
Avg holding period · 112 Days
ROIV
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Strategy Inc.

MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web

Read more on MSTR →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →